Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Consensus Rating of Buy from Analysts

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) have received an average rating of “Buy” from the three research firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price […]

Related Keywords

Thomson Reuter ,Geode Capital Management ,Longboard Pharmaceuticals ,Zacks Investment Research ,Nasdaq ,Longboard Pharmaceuticals Get Rating ,Td Asset Management Inc ,Cantor Fitzgerald ,Citigroup Inc ,Millennium Management ,Longboard Pharmaceuticals Inc ,Get Rating ,Investment Research ,Nasdaq Lbph ,Lbph ,Medical ,Ratings ,Consensus ,